Exploring the professional and personal impact of migraine: a cross-sectional study in Greece
Abstract
Background: Migraine is a chronic neurological disorder affecting over one billion individuals globally. It is a leading cause of disability, significantly impacting daily functioning, social relationships and work-related productivity. This study aims to explore the impact of migraine-related disability in everyday life in terms of missed days and productivity loss, as well as to identify work-related difficulties associated with migraine and the potential factors that exacerbate these difficulties. Methods: This cross-sectional study was conducted from October 2023 to June 2024, involving 604 adult patients with migraine in Greece, selected through a convenience sampling method. Data collected included socio-demographic and clinical information, obtained using two validated self-reported questionnaires: the Migraine Disability Assessment (MIDAS) and the HEADWORK questionnaire. Statistical analysis was performed using IBM SPSS (Version 20.0), and descriptive statistics, chi-square tests, t-tests and Spearman’s correlation were employed to evaluate the relationship between disability and work-related challenges. Results: The MIDAS score revealed a high level of disability, with 52.2% of participants classified in the Severe Disability grade. HEADWORK scores highlighted moderate-to-severe work-related difficulties, particularly concerning stress management and environmental factors such as noise and brightness. Females, patients experiencing migraine with aura, and…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 604 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.